Lipid-Lowering Therapy in Acute Coronary Syndromes

JAMA ◽

10.1001/jama.285.13.1758 ◽

2001 ◽

Vol 285 (13) ◽

pp. 1758 ◽

Author(s):

Frank M. Sacks

Keyword(s):

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

High intensity lipid‐lowering therapy after acute coronary syndromes: room for improvement

The Medical Journal of Australia ◽

10.5694/mja2.12055 ◽

2018 ◽

Vol 210 (2) ◽

pp. 73-74

Author(s):

Karam Kostner

Keyword(s):

High Intensity ◽

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial

American Heart Journal ◽

10.1016/j.ahj.2004.06.033 ◽

2005 ◽

Vol 149 (3) ◽

pp. 444-450 ◽

Author(s):

Charles S. Smith ◽

Christopher P. Cannon ◽

Carolyn H. McCabe ◽

Sabina A. Murphy ◽

Jane Bentley ◽

...

Keyword(s):

Acute Coronary Syndromes ◽

Early Initiation ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Early Initiation of Lipid-lowering Therapy for Acute Coronary Syndromes Improves Compliance With Guideline Recommendations: Observations From the Orbofiban in Patients With Unstable Coronary Syndromes (OPUS–TIMI-16) Trial

ACC Current Journal Review ◽

10.1016/j.accreview.2005.08.002 ◽

2005 ◽

Vol 14 (8) ◽

pp. 1-2

Author(s):

C.S. Smith ◽

C.P. Cannon ◽

C.H. McCabe ◽

S.A. Murphy ◽

J. Bentley ◽

...

Keyword(s):

Acute Coronary Syndromes ◽

Early Initiation ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

10.1016/s0140-6736(00)04257-4 ◽

2001 ◽

Vol 357 (9262) ◽

pp. 1063-1068 ◽

Author(s):

Herbert D Aronow ◽

Eric J Topol ◽

Matthew T Roe ◽

Penny L Houghtaling ◽

Katherine E Wolski ◽

...

Keyword(s):

Observational Study ◽

Acute Coronary Syndromes ◽

Early Mortality ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Patients on lipid-lowering therapy at the time of a myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndromes

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(02)81426-7 ◽

2002 ◽

Vol 39 ◽

pp. 318 ◽

Author(s):

Herbert D. Aronow ◽

Thomas McRae ◽

Marlin J. Quinn ◽

Eric J. Topol ◽

Michael Lincoff ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Salutary Effect ◽

Coronary Syndromes

Download Full-text

OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

Pharmacological Research ◽

10.1016/j.phrs.2021.105499 ◽

2021 ◽

pp. 105499

Author(s):

Maciej Banach ◽

Peter E. Penson ◽

Michal Vrablik ◽

Matjaz Bunc ◽

Krzysztof Dyrbus ◽

...

Keyword(s):

Acute Coronary Syndromes ◽

Expert Panel ◽

Position Paper ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design

Hellenic Journal of Cardiology ◽

10.1016/j.hjc.2018.10.002 ◽

2019 ◽

Vol 60 (4) ◽

pp. 249-253 ◽

Author(s):

Aristi Boulmpou ◽

Anastasios Kartas ◽

Ioannis Farmakis ◽

Stefanos Zafeiropoulos ◽

Vasileios Nevras ◽

...

Keyword(s):

Motivational Interviewing ◽

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Therapeutic Goals ◽

Lowering Therapy ◽

Coronary Syndromes ◽

Therapy Compliance

Download Full-text

Early lipid-lowering therapy after acute coronary syndromes

Inpharma Weekly ◽

10.2165/00128413-200112830-00027 ◽

2001 ◽

Vol &NA; (1283) ◽

pp. 12

Author(s):

&NA;

Keyword(s):

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Safety and tolerability of intensive lipid-lowering therapy after acute coronary syndromes: defining the role of ezetimibe in a comprehensive secondary prevention program

European Heart Journal ◽

10.1093/eurheartj/eht307.p686 ◽

2013 ◽

Vol 34 (suppl 1) ◽

pp. P686-P686

Author(s):

F. Colivicchi ◽

A. Aiello ◽

M. Tubaro ◽

M. Santini

Keyword(s):

Secondary Prevention ◽

Prevention Program ◽

Acute Coronary Syndromes ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Coronary Syndromes

Download Full-text

Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Journal of Thoracic Disease ◽

10.21037/jtd.2017.05.46 ◽

2017 ◽

Vol 9 (5) ◽

pp. 1345-1352 ◽

Author(s):

Yun-Yan Dai ◽

Hai-Shan Zhang ◽

Xin-Gang Zhang ◽

Qi-Gang Guan ◽

Yuan Gao ◽

...

Keyword(s):

Percutaneous Coronary Intervention ◽

Acute Coronary Syndromes ◽

Coronary Intervention ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Percutaneous Coronary ◽

Coronary Syndromes

Download Full-text